{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T15:44:25Z","timestamp":1648655065026},"reference-count":0,"publisher":"American Medical Association (AMA)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2019,8,6]]},"DOI":"10.1001\/jama.2019.11154","type":"journal-article","created":{"date-parts":[[2019,8,6]],"date-time":"2019-08-06T15:04:10Z","timestamp":1565103850000},"page":"393","source":"Crossref","is-referenced-by-count":0,"title":["Drug Approved for Inflammatory Nasal Cavity Condition"],"prefix":"10.1001","volume":"322","author":[{"given":"Rebecca","family":"Voelker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/article-pdf\/322\/5\/393\/17761804\/jama_voelker_2019_fd_190041.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,6]],"date-time":"2019-08-06T15:04:11Z","timestamp":1565103851000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2740700"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,6]]},"references-count":0,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,8,6]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.2019.11154","relation":{},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8,6]]}}}